Literature DB >> 7713195

Symptoms related to asthma and chronic bronchitis in three areas of Sweden.

E Björnsson1, P Plaschke, E Norrman, C Janson, B Lundbäck, A Rosenhall, N Lindholm, L Rosenhall, E Berglund, G Boman.   

Abstract

Does the prevalence of respiratory symptoms differ between regions? As a part of the European Community Respiratory Health Survey, we present data from an international questionnaire on asthma symptoms occurring during a 12 month period, smoking and symptoms of chronic bronchitis. The questionnaire was mailed to 10,800 persons aged 20-44 yrs living in three regions of Sweden (Västerbotten, Uppsala and Göteborg) with different environmental characteristics. The total response rate was 86%. Wheezing was reported by 20.5%, and the combination of wheezing without a cold and wheezing with breathlessness by 7.4%. The use of asthma medication was reported by 5.3%. Long-term cough and/or morning cough together with problems with phlegm was reported by 12.8%; the prevalence being highest in the most polluted area (Göteborg). When using multivariate analysis, no significant difference in asthma-related symptoms was found between the centres. Women reported cough more frequently, but otherwise gender did not influence symptom prevalence. Our results indicate that bronchitis symptoms occur more frequently in Göteborg, the most polluted of the Swedish centres, but that the prevalence rates of asthma-related symptoms do not differ between these three regions.

Entities:  

Mesh:

Year:  1994        PMID: 7713195     DOI: 10.1183/09031936.94.07122146

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

Review 1.  The role of smoking in allergy and asthma: lessons from the ECRHS.

Authors:  Simone Accordini; Christer Janson; Cecilie Svanes; Deborah Jarvis
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

2.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

3.  Asthma, airways responsiveness and air pollution in two contrasting districts of northern England.

Authors:  G Devereux; T Ayatollahi; R Ward; C Bromly; S J Bourke; S C Stenton; D J Hendrick
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

Review 4.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

5.  Insomnia is more common among subjects living in damp buildings.

Authors:  C Janson; D Norbäck; E Omenaas; T Gislason; L Nyström; R Jõgi; E Lindberg; M Gunnbjörnsdottir; E Norrman; T Wentzel-Larsen; C Svanes; E J Jensen; K Torén
Journal:  Occup Environ Med       Date:  2005-02       Impact factor: 4.402

6.  Prevalence of chronic bronchitis-asthma symptoms in biomass fuel exposed females.

Authors:  Kürşat Uzun; Bülent Ozbay; Erkan Ceylan; Mehmet Gencer; Ismail Zehir
Journal:  Environ Health Prev Med       Date:  2003-03       Impact factor: 3.674

7.  Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children.

Authors:  S K Weiland; A Hüsing; D P Strachan; P Rzehak; N Pearce
Journal:  Occup Environ Med       Date:  2004-07       Impact factor: 4.402

8.  West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma.

Authors:  Jan Lötvall; Linda Ekerljung; Erik P Rönmark; Göran Wennergren; Anders Lindén; Eva Rönmark; Kjell Torén; Bo Lundbäck
Journal:  Respir Res       Date:  2009-10-12

9.  Asthma and airways collapse in two heritable disorders of connective tissue.

Authors:  A W Morgan; S B Pearson; S Davies; H C Gooi; H A Bird
Journal:  Ann Rheum Dis       Date:  2007-04-05       Impact factor: 19.103

10.  Higher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study.

Authors:  Anders Bjerg; Linda Ekerljung; Jonas Eriksson; Inga Sif Ólafsdóttir; Roelinde Middelveld; Karl A Franklin; Bertil Forsberg; Kjell Larsson; Jan Lötvall; Kjell Torén; Sven-Erik Dahlén; Bo Lundbäck; Christer Janson
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.